Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Broad Effectiveness: Study With Aripiprazole

This study has been completed.
Sponsor:
Collaborator:
Otsuka America Pharmaceutical
Information provided by:
Otsuka Pharmaceutical Development & Commercialization, Inc.
ClinicalTrials.gov Identifier:
NCT00036361
First received: May 8, 2002
Last updated: November 7, 2013
Last verified: September 2007

May 8, 2002
November 7, 2013
July 2002
January 2003   (final data collection date for primary outcome measure)
Safety Assessments
Not Provided
Complete list of historical versions of study NCT00036361 on ClinicalTrials.gov Archive Site
Safety Assessments
Not Provided
Not Provided
Not Provided
 
Broad Effectiveness: Study With Aripiprazole
Broad Effectiveness: Study With Aripiprazole

The purpose of this study is to learn if aripiprazole is effective in the treatment of a large number of persons diagnosed with schizophrenia or schizoaffective disorders

Not Provided
Interventional
Phase 3
Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Schizophrenia
  • Schizoaffective Disorder
Drug: Aripiprazole
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
444
January 2003
January 2003   (final data collection date for primary outcome measure)
  • Patients with Schizophrenia or Schizoaffective Disorder
Both
18 Years to 75 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00036361
CN138-087
Not Provided
Not Provided
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka America Pharmaceutical
Not Provided
Otsuka Pharmaceutical Development & Commercialization, Inc.
September 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP